This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shasun Pharmaceuticals Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Sathish Kumar Raman Viswanathan
Introduction
Sathish Kumar Raman Viswanathan is an accomplished inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for therapeutic use. His work is characterized by a focus on improving the efficacy and safety of antipsychotic medications.
Latest Patents
Sathish Kumar Raman Viswanathan holds a patent for "Salts and hydrates of antipsychotics." This invention relates to a novel salt of a specific compound, (3aR,4S,7R,7aS)-2-[((1R,2R)-2-{[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl]methyl}cyclohexyl)methyl]hexahydro-1H-4,7-methanisoindol-1,3-dione, and its hydrates. The patent outlines methods for preparing this novel salt and its hydrates, providing a process for the preparation of lurasidone dihydrochloride. The process includes mixing lurasidone free base in an organic solvent system, subjecting the mixture to an acid proton source, and isolating the compound of lurasidone dihydrochloride.
Career Highlights
Sathish Kumar Raman Viswanathan is currently employed at Shasun Pharmaceuticals Limited, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug formulation and delivery systems, enhancing the therapeutic options available for patients.
Collaborations
He has collaborated with notable colleagues, including Vijayabaskar Veerappan and Srimurugan Sankareswaran, to further his research and development efforts in the pharmaceutical industry.
Conclusion
Sathish Kumar Raman Viswanathan is a prominent inventor whose work in the field of antipsychotic medications has the potential to improve patient outcomes significantly. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile